Why Do We Treat Obesity? Epidemiology

Similar documents
Diabetes Day for Primary Care Clinicians Advances in Diabetes Care

Know Your Number Aggregate Report Single Analysis Compared to National Averages

Heart Disease and Stroke Statistics 2010 Update. 2009, American Heart Association. All rights reserved.

Session 6B Appropriate Treatment of Obesity Demonstrates Clinical & Economic Success

The clinical and economic benefits of better treatment of adult Medicaid beneficiaries with diabetes

Current status on other health effects:

Statistical Fact Sheet Populations

DIABETES. A growing problem

A n aly tical m e t h o d s

Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan.

Age 18 years and older BMI 18.5 and < 25 kg/m 2

Smoking Status and Body Mass Index in the United States:

Judy Kruger, PhD, MS, Deborah A. Galuska, PhD, MPH, Mary K. Serdula, MD, MPH, Deborah A. Jones, PhD

Age 18 years and older BMI 18.5 and < 25 kg/m 2

Myths, Heart Disease and the Latino Population. Maria T. Vivaldi MD MGH Women s Heart Health Program. Hispanics constitute 16.3 % of US population!

YOUNG ADULT MEN AND MIDDLEaged

Hypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital

This slide set provides an overview of the impact of type 1 and type 2 diabetes mellitus in the United States, focusing on epidemiology, costs both

Impact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients

Obesity: Trends, Impact, Complexity

The Heart of a Woman. Karen E. Friday, M.D. Associate Professor of Medicine Section of Endocrinology Louisiana State University School of Medicine

CHRONIC DISEASE PREVALENCE AMONG ADULTS IN OHIO

Trends In CVD, Related Risk Factors, Prevention and Control In China

PREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS

The Metabolic Syndrome: Is It A Valid Concept? YES

CHAPTER 3 DIABETES MELLITUS, OBESITY, HYPERTENSION AND DYSLIPIDEMIA IN ADULT CENTRAL KERALA POPULATION

The Diabetes Prevention Program: Call for Action

Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes?

Fructose, Uric Acid and Hypertension in Children and Adolescents

The Global Agenda for the Prevention of Diabetes: Research Opportunities

Before the Pre. PREDIABETES Diagnosis, Management, Treatment. A few thoughts on diabetes.

Relationship of Body Mass Index, Waist Circumference and Cardiovascular Risk Factors in Chinese Adult 1

Overweight and Obesity in Older Persons: Impact Upon Health and Mortality Outcomes

The Who (Causes), What (Complications) and Where (Epidemiology) of Obesity.

Normal Parameters: Age 65 years and older BMI 23 and < 30 kg/m 2 Age years BMI 18.5 and < 25 kg/m 2

Prevenzione cardiovascolare e cambiamento degli stili di vita. Gian Franco Gensini

Total risk management of Cardiovascular diseases Nobuhiro Yamada

Healthy Montgomery Obesity Work Group Montgomery County Obesity Profile July 19, 2012

HEALTH PROMOTION AND CHRONIC DISEASE PREVENTION PROGRAM OREGON STATE OF THE HEART AND STROKE REPORT 2001 PREPARED BY.

Student Paper PRACTICE-BASED RESEARCH

UW MIRT 2005 ABSTRACTS

OBESITY: TRENDS AND IMPLICATIONS. Mark Skillan, M.D. ACSW SEAC November 18, 2011

Identification of subjects at high risk for cardiovascular disease

Lack of documentation on overweight & obese status in patients admitted to the coronary care unit: Results from the CCU study

Depok-Indonesia STEPS Survey 2003

Overweight/Obesity & Physical Inactivity. Healthy Kansans 2010 Steering Committee Meeting April 22, 2005

La obesidad puede matar: el papel de primaria de la salud y la prevención del cáncer.

SUPPLEMENTARY DATA. Appendix

OBESITY IN PRIMARY CARE

«Πατσζαρκία και Καρδιαγγειακή Νόζος»

Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University

Objectives 10/11/2013. Diabetes- The Real Cost of Sugar. Diabetes 101: What is Diabetes. By Ruth Nekonchuk RD CDE LMNT

Complications of Pregnancy and Lifetime Risk to Health. Brian McCulloch MD Advocate Lutheran General Hospital September 26, 2015

Association between arterial stiffness and cardiovascular risk factors in a pediatric population

290 Biomed Environ Sci, 2016; 29(4):

The Burden Report: Cardiovascular Disease & Stroke in Texas

3/20/2011. Body Mass Index (kg/[m 2 ]) Age at Issue (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Mokdad A.H.

Diabetes is an illness that affects an estimated. Outcomes and Medication Use in a Longitudinal Cohort of Type 2 Diabetes Patients, 2006 to 2012

ARTICLE. Prevalence of Diabetes and Impaired Fasting Glucose Levels Among US Adolescents. National Health and Nutrition Examination Survey,

Cardiovascular Disease After Spinal Cord Injury: Achieving Best Practice. Suzanne Groah, MD, MSPH Walter Reed Army Medical Center February 12, 2010

Epidemiologic Measure of Association

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Supplement materials:

Metabolic Syndrome among Type-2 Diabetic Patients in Benghazi- Libya: A pilot study. Arab Medical University. Benghazi, Libya

Energy Balance Equation

Abdominal volume index and conicity index in predicting metabolic abnormalities in young women of different socioeconomic class

Is there an association between waist circumference and type 2 diabetes or impaired fasting glucose in US adolescents?

Prevalence of Overweight Among Anchorage Children: A Study of Anchorage School District Data:

Normal Fasting Plasma Glucose and Risk of Type 2 Diabetes Diagnosis

Epidemiology of Obesity in Japan

Presenter Disclosure Information

Relations of body weight status in early adulthood and weight changes until middle age with metabolic syndrome in the Chinese population

Jackson Heart Study Manuscript Proposal Form

Obesity in the US: Understanding the Data on Disparities in Children Cynthia Ogden, PhD, MRP

Michigan s Diabetes Crisis: Today and Future Trends. Dr. William Rowley Institute for Alternative Futures

A Summary Report: 2003

Using the New Hypertension Guidelines

Cardiovascular risk assessment in the metabolic syndrome: results from the Prospective Cardiovascular Munster (PROCAM) Study

Chapter 1: CKD in the General Population

Optimal blood pressure targets in chronic kidney disease

METABOLIC SYNDROME IN A JORDANIAN COHORT: DEMOGRAPHY, COMPLICATIONS AND PREDICTORS OF CARDIOVASCULAR DISEASES

Epidemiology of Diabetes Mellitus in Asia

Page down (pdf converstion error)

A COMPREHENSIVE REPORT ISSUED BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS IN PARTNERSHIP WITH:

Diabetes in the Latino/Hispanic Population The case for education and outreach

Sleep Apnea: Vascular and Metabolic Complications

Policy Brief: Weight Loss Success among Overweight and Obese Women of Mexican-origin

7/6/2012. University Pharmacy 5254 Anthony Wayne Drive Detroit, MI (313)

ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults

INFLUENCE OF OBESITY ASSESSMENTS ON CARDIOMETABOLIC RISKS IN AFRICAN AND EUROPEAN AMERICAN WOMEN

The National Diabetes Prevention Program in Washington State March 2012

National Health & Morbidity Survey 2015; NCD Risk Factors

Prevention and Control of Obesity in the US: A Challenging Problem

Looking Toward State Health Assessment.

Andrejs Kalvelis 1, MD, PhD, Inga Stukena 2, MD, Guntis Bahs 3 MD, PhD & Aivars Lejnieks 4, MD, PhD ABSTRACT INTRODUCTION. Riga Stradins University

Glycemic index, glycemic load, and the risk of acute myocardial infarction in middle-aged Finnish men:

Obesity and Medical Nutrition Therapy. Deborah B. Munchmeyer Program Manager, SCDHHS Coverage and Benefit Design March 10, 2018

Michael S. Blaiss, MD

Diabetes, Diet and SMI: How can we make a difference?

Chapter Two Renal function measures in the adolescent NHANES population

Transcription:

Why Do We Treat Obesity? Epidemiology

Epidemiology of Obesity U.S. Epidemic 2

More than Two Thirds of US Adults Are Overweight or Obese 87.5 NHANES Data US Adults Age 2 Years (Crude Estimate) Population (%) 7. 52.5 35. 17.5 3.5 33.9 35.9 35.1 22.5 12.8 14.1 14.5 3.5 32. 31.5 32. 34. 34.4 33.3 33.9 1.7-fold increase in obesity since 1962 BMI 3 BMI 25-29. 1962 1974 198 1994 2 28 21 212 BMI = body mass index (in kg/m 2 ); NHANES = National Health and Nutrition Examination Survey (x-axis lists last year of each survey). Flegal KM, et al. Int J Obes Relat Metab Disord. 1998;22:39-47; Flegal KM, et al. JAMA. 22;288:1723-1727; Flegal KM, et al. JAMA. 21;33:235-241; Flegal KM, et al. JAMA. 212;37:491-497. Ogden CL, et al. JAMA. 214;311:86-814. 3

Obesity Rates Are Increasing Across the United States BFRSS Data 199 2 21 Adults with BMI 3 kg/m 2 No data <1% 1% 14% 15% 19% 2% 24% 25% 29% 3% (21) 3%-34% (211-213) 35% 211* 212* 213* *BFRSS methodology changed in 211 and data from 21 and earlier cannot be compared to data from 211 onward. BRFSS = Behavioral Risk Factor Surveillance System; BMI = body mass index. CDC. Adult obesity facts. Available at: http://www.cdc.gov/obesity/data/trends.html. 4

Prevalence of Obesity Varies With Race, Ethnicity, and Sex 75 NHANES Data US Adults Age 2 Years With BMI 3 6 Population (%) 45 3 15 White men White women Black men Black women Latino men* Latina women* 198 1994 2 28 21 212 *Estimates based on Mexican Americans only for 198-28. BMI = body mass index (in kg/m 2 ); NHANES = National Health and Nutrition Examination Survey (x-axis lists last year of each survey). Flegal KM, et al. Int J Obes Relat Metab Disord. 1998;22:39-47; Flegal KM, et al. JAMA. 22 ;288:1723-1727; Flegal KM, et al. JAMA. 21;33:235-241; Flegal KM, et al. JAMA. 212;37:491-497. Ogden CL, et al. JAMA. 214;311:86-814. 5

Epidemiology of Obesity Worldwide Trends 6

Worldwide Prevalence of Obesity 215 Women, Age 18 Years Men, Age 18 Years BMI 3 kg/m 2 <1.% 1.%-19.9% 2.%-29.9% 3% Data not available Not applicable WHO. Global Health Observatory Map Gallery. Available at: http://gamapserver.who.int/maplibrary/app/searchresults.aspx. 7

Obesity Increase Is Associated with Rising Rates of Diabetes Worldwide Current estimated prevalence: 415 million worldwide By 24, 642 million people worldwide are expected to have diabetes IDF. Diabetes Atlas Update 215. Available at: http://www.idf.org/sites/default/files/atlas7e-poster.pdf. 8

Strong Association Between Weight Gain and Diabetes: Rural India Obesity* Diabetes Population (%) 2 15 1 5 2. 75% increase 8 191% increase 17.1 Population (%) 6 4 2.2 2 6.4 1989 23 1989 23 *BMI 25 kg/m 2. BMI = body mass index. Ramachandran A, et al. Diabetologia. 24;47:86-865. 9

The Increase in Diabetes Parallels the Increase in Obesity in the United States Obesity* Diabetes 45 96% increase 12 43% increase 36 35.1 1 9.3 Population (%) 27 18 17.9 Population (%) 8 6 4 6.5 9 2 1998 212 1998 214 *BMI 3 kg/m 2. BMI = body mass index. CDC. National diabetes statistics report, 214. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, 214. Mokdad AH, et al. JAMA. 1999;282:1519-1522; Mokdad AH, et al. Diabetes Care. 2;23:1278-1283; Ogden CL, et al. JAMA. 214;311:86-814. 1

Epidemiology of Obesity Impact on Clinical Outcomes 11

The Risk of Chronic Conditions Increases With BMI Women Men Type 2 diabetes Hypertension Cholelithiasis Coronary heart disease Relative Risk 6 5 4 3 2 1 <21 22 23 24 25 26 27 28 29 3 BMI (kg/m 2 ) 6 5 4 3 2 1 <21 22 23 24 25 26 27 28 29 3 BMI (kg/m 2 ) Increased abdominal adiposity is highly correlated with insulin resistance and type 2 diabetes BMI = body mass index. Willett WC, et al. N Engl J Med. 1999;341:427-434. Carey VJ, et al. Am J Epidemiol. 1997;145:614-619. 12

Prevalence of Weight-Related Comorbidities in the US NHANES 27-21 US Adults Age 18 Years (N=12,175) Patients (%) 6 5 4 3 2 1 19.8 26.4 35.6 28.6 44.2 49.7 Hypertension Dyslipidemia Diabetes SBP 14 mmhg, DBP 9 mmhg, or using anti-ht drug Normal weight Overweight Obese Non-HDL-C 16 mg/dl or using cholesterol-lowering drug 5.4 8.2 18.5 FPG 126 mg/dl, A1C 6.5%, or DM diagnosis Normal weight = BMI 18 to <25 kg/m 2 ; overweight = BMI 25 to <3 kg/m 2 ; obese = BMI 3 kg/m 2 BMI = body mass index; DM = diabetes mellitus; DBP = diastolic blood pressure; HDL-C = high density lipoprotein cholesterol; HT = hypertension; SBP = systolic blood pressure. Saydah S, et al. Obesity (Silver Spring). 214;22:1888-1895. 13

Mortality Increases with BMI Cancer Prevention Study II (N=1,46,154) Relative risk of death* 3. 2.6 2.2 1.8 1.4 1..6 2.2 1.8 1.4 1..6 Men Women Normal Overweight CVD death risk significantly increased CVD death risk significantly increased Obese Cardiovascular disease Cancer All other causes *Cox proportional hazards model adjusted for age at enrollment, education, physical activity, alcohol use, marital status, aspirin use, fat consumption, vegetable consumption, and use estrogen replacement therapy in women. Calle EE, et al. New Engl J Med. 1999;341:197-115. 14

All-Cause Mortality Increases with BMI National Institutes of Health AARP Cohort Study, 1996-29 (N=19,947 Never-Smokers) Men Women Multivariate hazard ratio* 3 2.5 2 1.5 1 1.28 1.2 P<.5 for linear trend 1.15 1 1 1.2 1.25 1.46 1.7 2.13 2.43 2.59.5 <18.5 18.5-22.4 22.5-24.9 25.-27.4 27.5-29.9 3. (Referent) Body mass index (kg/m 2 ) *Regression analyses adjusted for age, race/ethnicity, education, leisure-time physical activity, and alcohol consumption. Adams KF, et al. Am J Epidemiol. 214;179:135-144. 15

Earlier Weight Gain Increases Total Mortality Risk National Institutes of Health AARP Cohort Study, 1996-29 (N=19,947 Never-Smokers) Multivariate hazard ratio* 2.5 2 1.5 1.5 Men Women 2.4 1.68 1.68 1.26 1.32 1.12.98.96 Study entry 5 35 18 (Age 5-71) Age at which BMI 25 kg/m 2 *Regression analyses adjusted for age, race/ethnicity, education, leisure-time physical activity, and alcohol consumption. Adams KF, et al. Am J Epidemiol. 214;179:135-144. 16

Racial Differences in BMI-Mortality Association National Health Interview Survey, 1997-26 Never Smokers (N=32,975) Ever Smokers (N=38,7) Age-standardized all-cause mortality rates for persons aged 35-75 years without a history of heart disease or cancer at baseline. Bars indicate upper or lower 95% confidence intervals. Jackson CL, et al. Obesity (Silver Spring). 214;22:842-851. 17

Epidemiology of Obesity Economic Impact 18

The Effect of Weight on Healthcare Costs U.S. Adults (N=23,689) Medical expenditures Confidence interval Population distribution Cawley J, Meyerhoefer C. J Health Econ. 212;31:219-23. 19

Obesity-Related Illness Accounts for One-Fifth of U.S. Healthcare Costs Obesity Costs 1 U.S. Adults Age 18 Years Diabetes Costs 2 U.S. Residents, All Ages 1. 14 Health Expenditures (25 US$, billions) 75. 5. 25. Total $923.2 billion Health Expenditures (27 US$, billions) 15 7 35 Total $1,3 billion. Obesity $19.2 billion 2.6% of total costs Diabetes $176 billion 13.5% of total costs 1. Cawley J, Meyerhoefer C. J Health Econ. 212;31:219-23. 2. ADA. Diabetes Care. 213;36:133-146. 2

Medicare Spending Is Rising Significantly Faster in the Overweight Population Annual Increase in Medicare Expenditures 1997-26 35 P=.1 Cost per year (26 US$) 28 21 14 7 $122 P=.1 $23 $271 Normal weight Overweight Obese After adjustment for obesity-related chronic conditions, interactions were no longer significant Alley D, et al. Arch Intern Med. 212;172:277-278. 21

Obesity Significantly Increases Medicare Expenditures 14 Mean Expenditures in 23 Individuals >65 Years of Age Normal (BMI <25) Obese (BMI 3) ** $12,841 Costs (25 US$) 15 7 35 $3,247 $3,888 $982 ** $1,37 ** $2,331 $1,528 $1,443 ** $1,12 $1,654 Inpatient Outpatient Prescription drugshealthcare provider Total* *Includes dental and other costs not shown. **P.1 vs normal weight. BMI = body mass index in kg/m 2. Wilkins TL, et al. Obesity (Silver Spring). 212;2:124-1248. 22

Weight Loss Reduces Lifetime Healthcare Costs Projected Lifetime Healthcare Expenditures Obese Individuals <45 Years of Age Costs (US$) 2813-2813 -5625 + $23 - $357 + $93 - $48 + $17 Cost offsets Prolonged life Improved health -8438 - $81-1125 5% Weight Loss for 2 Years Total Benefit $334 Permanent 5% Weight Loss Total Benefit $315 Permanent 1% Weight Loss Total Benefit $64 Dall TM, et al. Am J Prev Med. 211;4:338-344. 23

Summary Obesity is increasing globally Rates of obesity have risen dramatically in the United States over the past 4 decades The increase in obesity is strongly associated with the increase in diabetes in the U.S. and worldwide Obesity is costly 24